LCI-PED-NOS-EXER-001: Exercise in Pediatric Oncology Patients
ConditionPediatric Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age2-25
SponsorWake Forest University Health Sciences
About this trial
The purpose of this study is to see if there are physical and emotional benefits to participating in a structured exercise regimen for those who are ages 2-25, are newly diagnosed with a blood or solid tumor cancer, and are currently undergoing or will begin cancer treatment.
Eligibility criteria
Qualifiers
Ages 2-25 at time of consent
Subject has newly diagnosed cancer per Investigator, and is planning to undergo chemotherapy for treatment of malignancy for at least 3 full cycles
Ability of subject (and/or parent/guardian) to read and understand the English or Spanish language
As determined and documented by the enrolling investigator, ability of the subject to understand and comply with study procedures for the entire length of the study
Disqualifiers
Known cardiac dysfunction that, in the opinion of the investigator, would be unsafe for the child to participate in the exercise program
Any other uncontrolled intercurrent illness/medical condition or psychiatric illness/social situations that would limit compliance with study requirements or would be considered unsafe for the child to participate as determined by the Investigator.
Recent (within 4 weeks of enrollment) or planned surgery that will result in prolonged limited mobility not amendable to exercise modifications per investigator discretion
Primary CNS Tumor
Trial design
Treatments tested in this trial
- "Just Move" Exercise
- Standard of Care Exercise
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Wake Forest University Health Sciences
Lead sponsor
Atrium Health Levine Cancer Institute
Collaborator
Source ClinicalTrials.gov